Cash from Operations (Annual) Chart

View Cash from Operations (Annual) for CBGL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Operations (Annual) Chart
Start Trial

Historical Cash from Operations (Annual) Data

View and export this data back to 2007. Start Trial.
Date Value
August 31, 2025 -0.2899M
August 31, 2024 -0.0651M
August 31, 2023 -0.0982M
August 31, 2022 -0.9839M
August 31, 2021 -1.471M
August 31, 2020 -1.522M
August 31, 2019 -0.1094M
August 31, 2018 -0.0357M
August 31, 2017 -0.0002M
August 31, 2016 -0.0008M
Date Value
August 31, 2015 -0.0459M
August 31, 2014 -0.0394M
August 31, 2013 -0.0455M
August 31, 2012 -0.0488M
August 31, 2011 -0.053M
August 31, 2010 -0.0734M
August 31, 2009 -0.0864M
August 31, 2008 -0.0708M
August 31, 2007 -0.0274M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Annual) Range, Past 5 Years

View Cash from Operations (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Annual) Benchmarks

View Cash from Operations (Annual) Benchmarks
Start Trial
Filana Therapeutics, Inc. -32.25M
CorMedix, Inc. 175.05M
Eloxx Pharmaceuticals, Inc. -6.327M
Breakthrough Chemistry, Inc. -0.0131M
BioStem Technologies, Inc. 9.941M